Robert V. Moquin

1.3k total citations
19 papers, 568 citations indexed

About

Robert V. Moquin is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Robert V. Moquin has authored 19 papers receiving a total of 568 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Organic Chemistry, 10 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Robert V. Moquin's work include Melanoma and MAPK Pathways (6 papers), Synthesis and biological activity (3 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (3 papers). Robert V. Moquin is often cited by papers focused on Melanoma and MAPK Pathways (6 papers), Synthesis and biological activity (3 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (3 papers). Robert V. Moquin collaborates with scholars based in United States, Germany and Japan. Robert V. Moquin's co-authors include Joel C. Barrish, Jagabandhu Das, James C. Lin, Arthur M. Doweyko, John Wityak, Ding Ren Shen, Gary L. Schieven, Steven H. Spergel, David Floyd and Sidney Pitt and has published in prestigious journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and Tetrahedron Letters.

In The Last Decade

Robert V. Moquin

19 papers receiving 545 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert V. Moquin United States 14 357 224 98 49 37 19 568
Kimberly G. Petrov United States 8 277 0.8× 288 1.3× 181 1.8× 79 1.6× 32 0.9× 9 588
Steven H. Spergel United States 16 787 2.2× 281 1.3× 89 0.9× 28 0.6× 38 1.0× 26 1.0k
Robert A. Mantei United States 15 258 0.7× 308 1.4× 111 1.1× 62 1.3× 15 0.4× 24 621
James M. Hamby United States 17 349 1.0× 542 2.4× 121 1.2× 50 1.0× 16 0.4× 32 828
R. Thomas Winters United States 14 380 1.1× 263 1.2× 155 1.6× 43 0.9× 16 0.4× 24 643
M. Sabat United States 16 354 1.0× 249 1.1× 86 0.9× 63 1.3× 14 0.4× 32 621
Peter Chua Canada 11 323 0.9× 443 2.0× 111 1.1× 28 0.6× 33 0.9× 14 766
Guy Fournet France 20 411 1.2× 279 1.2× 150 1.5× 22 0.4× 37 1.0× 47 844
David P. Kay United States 9 226 0.6× 356 1.6× 169 1.7× 33 0.7× 13 0.4× 12 608
Nalin L. Subasinghe United States 12 238 0.7× 198 0.9× 49 0.5× 21 0.4× 48 1.3× 17 419

Countries citing papers authored by Robert V. Moquin

Since Specialization
Citations

This map shows the geographic impact of Robert V. Moquin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert V. Moquin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert V. Moquin more than expected).

Fields of papers citing papers by Robert V. Moquin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert V. Moquin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert V. Moquin. The network helps show where Robert V. Moquin may publish in the future.

Co-authorship network of co-authors of Robert V. Moquin

This figure shows the co-authorship network connecting the top 25 collaborators of Robert V. Moquin. A scholar is included among the top collaborators of Robert V. Moquin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert V. Moquin. Robert V. Moquin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Das, Jagabandhu, Robert V. Moquin, Alaric J. Dyckman, et al.. (2010). 5-Amino-pyrazoles as potent and selective p38α inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(23). 6886–6889. 19 indexed citations
2.
Kempson, James, Junqing Guo, Jagabandhu Das, et al.. (2009). Synthesis, initial SAR and biological evaluation of 1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridin-4-amine derived inhibitors of IκB kinase. Bioorganic & Medicinal Chemistry Letters. 19(10). 2646–2649. 16 indexed citations
3.
Das, Jagabandhu, Robert V. Moquin, Sidney Pitt, et al.. (2008). Pyrazolo-pyrimidines: A novel heterocyclic scaffold for potent and selective p38α inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(8). 2652–2657. 37 indexed citations
4.
Kim, Soong‐Hoon, John S. Tokarski, Kenneth J. Leavitt, et al.. (2007). Identification of 2-amino-5-(thioaryl)thiazoles as inhibitors of nerve growth factor receptor TrkA. Bioorganic & Medicinal Chemistry Letters. 18(2). 634–639. 19 indexed citations
5.
Das, Jagabandhu, Chunjian Liu, Robert V. Moquin, et al.. (2006). Discovery and SAR of 2-amino-5-(thioaryl)thiazoles as potent and selective Itk inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(14). 3706–3712. 64 indexed citations
6.
Das, Jagabandhu, Chunjian Liu, Robert V. Moquin, et al.. (2006). Discovery and SAR of 2-amino-5-[(thiomethyl)aryl]thiazoles as potent and selective Itk inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(9). 2411–2415. 31 indexed citations
7.
Wityak, John, Jagabandhu Das, Robert V. Moquin, et al.. (2003). Discovery and initial SAR of 2-amino-5-carboxamidothiazoles as inhibitors of the Src-family kinase p56Lck. Bioorganic & Medicinal Chemistry Letters. 13(22). 4007–4010. 39 indexed citations
8.
Humphreys, W. Griffith, Mary T. Obermeier, Samuel S. Chong, et al.. (2003). Oxidative activation of acylguanidine prodrugs: intestinal presystemic activation in rats limits absorption and can be inhibited by co-administration of ketoconazole. Xenobiotica. 33(1). 93–106. 11 indexed citations
9.
Das, Jagabandhu, Robert V. Moquin, James C. Lin, et al.. (2003). Discovery of 2-amino-heteroaryl-benzothiazole-6-anilides as potent p56lck inhibitors. Bioorganic & Medicinal Chemistry Letters. 13(15). 2587–2590. 92 indexed citations
10.
Das, Jagabandhu, James C. Lin, Robert V. Moquin, et al.. (2003). Molecular design, synthesis, and structure–Activity relationships leading to the potent and selective p56lck inhibitor BMS-243117. Bioorganic & Medicinal Chemistry Letters. 13(13). 2145–2149. 47 indexed citations
11.
Das, Jagabandhu, S. David Kimball, Steven E. Hall, et al.. (2002). Molecular design and structure–Activity relationships leading to the potent, selective, and orally active thrombin active site inhibitor BMS-189664. Bioorganic & Medicinal Chemistry Letters. 12(1). 45–49. 10 indexed citations
12.
Chen, Ping, Edwin J. Iwanowicz, Derek Norris, et al.. (2002). Synthesis and SAR of novel imidazoquinoxaline-Based Lck inhibitors: improvement of cell potency. Bioorganic & Medicinal Chemistry Letters. 12(21). 3153–3156. 13 indexed citations
13.
Norris, Derek, Ping Chen, Joel C. Barrish, et al.. (2001). Synthesis of imidazo[1,5-a]quinoxalin-4(5H)-one template via a novel intramolecular cyclization process. Tetrahedron Letters. 42(26). 4297–4299. 13 indexed citations
14.
Floyd, David, S. David Kimball, John Krapcho, et al.. (1992). Benzazepinone calcium channel blockers. 2. Structure activity and drug metabolism studies leading to potent antihypertensive agents. Comparison with benzothiazepinones. Journal of Medicinal Chemistry. 35(4). 756–772. 56 indexed citations
15.
Kimball, S. David, David Floyd, J. Das, et al.. (1992). Benzazepinone calcium channel blockers. 4. Structure-activity overview and intracellular binding site. Journal of Medicinal Chemistry. 35(4). 780–793. 38 indexed citations
16.
Weller, Harold N., Arthur V. Miller, Robert V. Moquin, et al.. (1992). Benzothiadiazine dioxides: A new class of potent angiotensin-II (AT1) receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 2(9). 1115–1120. 12 indexed citations
17.
Floyd, David, et al.. (1991). ChemInform Abstract: Synthesis of Benzazepinone and 3‐Methylbenzothiazepinone Analogues of Diltiazem.. ChemInform. 22(7). 4 indexed citations
18.
Floyd, David, Robert V. Moquin, Karnail S. Atwal, et al.. (1990). Synthesis of benzazepinone and 3-methylbenzothiazepinone analogs of diltiazem. The Journal of Organic Chemistry. 55(21). 5572–5579. 34 indexed citations
19.
Sauers, Ronald R., et al.. (1987). Synthesis and photochemistry of heterocyclic norbornenyl ketones. The Journal of Organic Chemistry. 52(25). 5501–5505. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kimberly G. Petrov Breakdown of academic impact, for papers by Steven H. Spergel Breakdown of academic impact, for papers by Robert A. Mantei Breakdown of academic impact, for papers by James M. Hamby Breakdown of academic impact, for papers by R. Thomas Winters Breakdown of academic impact, for papers by M. Sabat Breakdown of academic impact, for papers by Peter Chua Breakdown of academic impact, for papers by Guy Fournet Breakdown of academic impact, for papers by David P. Kay Breakdown of academic impact, for papers by Nalin L. Subasinghe
Rankless by CCL
2026